Pharma: A major pharmaceutical company's stock fell more than 10% following its third consecutive trial failure within a week.
🚨 Stock alert! Novartis shares plummeted on Tuesday following underwhelming results from their del-desiran drug trial, leaving investors disappointed. Stay tuned for updates on this evolving situation! 📉💊 #Novartis #PharmaNews #Investing
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
